Old Articles: <Older 2011-2020 Newer> |
|
The Motley Fool January 8, 2008 Brian Orelli |
Brits May Bludgeon Drug Companies The U.K.'s National Health Service delivers a shock to drugmakers; it is considering a 10% drop in the rate that it pays for drugs, to help it reach its goal of a 3% reduction in the nation's overall health-care bill. |
InternetNews January 7, 2008 |
Intel to Fight EU Antitrust Charges Intel will respond to the European Commission's charges of illegal moves to hurt AMD. |
Bank Technology News January 2008 Anthony Malakian |
Data Processing: Forestalling a Market Data Overload Thanks to Reg NMS in the U.S. and MiFID in Europe, market data volume is on the rise and will continue to grow gangbusters. Investing in infrastructure will be a way of life. |
Financial Advisor January 2008 Jeff Schlegel |
Another BRIC In The Wall Winston Churchill once famously described Russia as a riddle wrapped in a mystery inside an enigma. Investors today might feel the same way, given the dichotomy between its enticing growth prospects and the uncertainties raised by the increasing authoritarianism of President Vladimir Putin. |
Managed Care December 2007 Tom Reinke |
U.S. Health Insurers Find Opportunities Overseas The United Kingdom is proving hospitable to UnitedHealth Group and Aetna, and there is business to be had elsewhere in Europe and on other continents |
Global Services January 1, 2008 Verma & Vashistha |
The Future of M&As The next few years will witness an increase in the volume and aggregate value of M&As in the global IT and BPO service provider landscape. These deals will reflect providers' strategies to broad-base their presence across Europe and the Asia-Pacific regions. |
Global Services December 28, 2007 Adyasha Sinha |
EMEA: Hotspot for 2008 With Continental Europe expected to spend 60% more on offshoring in '08 than last year, a recent report identifies 13 hot locations in the EMEA region suitable for outsourcing. |
The Motley Fool December 31, 2007 Buz Livingston |
A Toast to Absolut Absolut, the Swedish vodka maker is up for sale, after the Swedish Parliament decides to auction off Vin & Spirit, Absolut's parent company. |
The Motley Fool December 31, 2007 Brian Orelli |
Boston Scientific Restarts Its Heart Boston Scientific receives European approval for its defibrillator, giving the company a revenue boost even if the U.S. approval is delayed. |
The Motley Fool December 31, 2007 Todd Wenning |
Best Stock for 2008: Lloyds TSB A bank that's actually worth buying. Lloyds TSB is a U.K.-based retail bank that actually generates most of its revenue from its life insurance and pension/investment wing. Investors, take note. |
<Older 2011-2020 Newer> Return to current articles. |